Better genetic risk prediction for open-angle glaucoma

Optimizing genetic risk models for primary open-angle glaucoma through expanded population genomic analysis

NIH-funded research East Carolina University · NIH-10879124

This project will build more accurate genetic risk tools for people at risk of open-angle glaucoma by including more diverse ancestry groups in the analysis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Carolina University NIH-funded
Lab location1 site (Greenville, United States)
Project IDNIH-10879124 on NIH RePORTER

What this research studies

You will be reading about work that combines clinical and genetic information from the largest worldwide datasets of people with and without open-angle glaucoma, with special focus on African and continental American ancestry. Researchers will run large-scale genetic meta-analyses to find new genetic regions linked to glaucoma, use admixture mapping to spot regions where ancestry affects risk, and fine-map key signals. They will then update polygenic risk scores so they reflect the full range of genetic variation across ancestries. The aim is to make genetic risk predictions more accurate and useful for diverse patient groups.

Who could benefit from this research

Good fit: People with or at risk for open-angle glaucoma—especially individuals of African, African-American, or continental American ancestry—would be most relevant to the work and any related data collection.

Not a fit: Patients with other glaucoma types or those seeking immediate new treatments may not see direct short-term benefit because the project focuses on improving genetic risk prediction rather than delivering a therapy.

Why it matters

Potential benefit: If successful, this could produce genetic tests that identify higher glaucoma risk earlier and more accurately for people from African and American ancestry groups, enabling earlier monitoring and care.

How similar studies have performed: Prior studies have produced useful polygenic risk scores in European populations but those scores often perform poorly in African and American ancestry groups, so this work builds on known methods to address that gap.

Where this research is happening

Greenville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.